Serial Number:
86328553
Mark:
T
Status:
Abandoned-No Statement of Use filed
Status Date:
01-23-2017
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease
Mark Description:
The mark consists of a stylized letter "T", a triangle with a dot in the middle and an incomplete square.
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
10-28-2014
Owner:
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
01-23-2017
Business Name:
MORRISON & FOERSTER LLP
Correspondent Name:
